• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Hematology

Increased blood–urea–nitrogen-to-albumin ratio associated with increased mortality in coronavirus disease

bySiwen LiuandAlex Chan
February 10, 2025
in Hematology, Infectious Disease, Pulmonology
Reading Time: 2 mins read
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Share on FacebookShare on Twitter

Association between blood–urea–nitrogen-to-albumin ratio and in-hospital mortality in patients diagnosed with coronavirus disease 2019: a retrospective cohort study

1. Increased blood–urea–nitrogen-to-albumin ratio was associated with increased risk of in-hospital mortality among patients with COVID-19.

Evidence Rating Level: 2 (Good)

Blood–urea–nitrogen-to-albumin ratio (BAR) is recognized as a novel short-term prognostic index, and elevated BAR has been linked to worse prognosis among patients hospitalized for coronavirus disease 2019 (COVID-19). However, research on the relationship between BAR and in-hospital mortality associated with COVID-19 is limited. This retrospective cohort study thus examined the association between BAR and in-hospital mortality in patients with COVID-19 in China. This study included patients over 18 years old who were hospitalized with COVID-19 from December 2022 to March 2023. In-hospital mortality was characterized as any death occurring during patient hospitalization or within 24 hours of discharge from the hospital. BAR (mg/g) was calculated using the initial serum blood–urea–nitrogen (mg/dL) divided by serum albumin (g/dL). Patients were divided into tertiles based on BAR values: tertile I (BAR, 1.134–3.932 [n = 341]); tertile II (BAR, 3.944–5.793 [n = 343]); and tertile III (BAR, 5.811–48.3 [n = 343]). In total, 1,027 patients were included in this study (mean [SD] age, 72.1 [13] years; 569 males [55.4%]), of whom 117 patients (11.4%) died from various causes during hospitalization. Patients in the highest BAR tertile had a higher risk of in-hospital mortality (adjusted hazard ratio [HR] 2.44 [95% confidence interval CI 1.24–4.79]) compared to those in the lowest tertile. Additionally, for every 1-unit increase in BAR, the risk of in-hospital mortality increased by 6% (adjusted HR 1.06 [95% CI 1.03–1.08]). Stratified and interaction analyses found that the association between BAR and in-hospital mortality due to COVID-19 remained consistent across various subgroups, including age, sex, COVID-19 severity, hypertension, coronary heart disease, and diabetes mellitus. Overall, this study found increased BAR to be associated with an increased risk of in-hospital mortality among patients with COVID-19. As this study mainly focused on patients with the Omicron variant of SARS-CoV-2, future studies are needed to confirm study findings. 

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Artificial intelligence (AI)-triggered rapid response notifications were associated with lower mortality among inpatients

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

2 Minute Medicine Rewind August 31, 2026

Tags: COVID-19critical careinfectious diseaseinternal medicineSARS-CoV-2
Previous Post

Direct oral anticoagulants have similar bleeding risk compared with aspirin

Next Post

#VisualAbstract: Liraglutide for 56 Weeks plus lifestyle interventions reduced BMI and Body Weight in Children with Obesity

RelatedReports

Artificial Intelligence

Artificial intelligence (AI)-triggered rapid response notifications were associated with lower mortality among inpatients

October 2, 2026
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Emergency

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

September 1, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Weekly Rewinds

2 Minute Medicine Rewind August 31, 2026

August 31, 2026
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

August 4, 2026
Next Post
#VisualAbstract: Liraglutide for 56 Weeks plus lifestyle interventions reduced BMI and Body Weight in Children with Obesity

#VisualAbstract: Liraglutide for 56 Weeks plus lifestyle interventions reduced BMI and Body Weight in Children with Obesity

Increasing survival rates for patients with acute liver failure

Characterization of the increased incidence of alcohol-associated hepatitis noted in Ontario, Canada in past two decades

Drug-coated balloons are noninferior to drug-eluting stents for treatment of small vessel coronary artery disease

Catheter-guided aortic valve replacement and angioplasty has favorable outcomes compared to surgical intervention

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
  • Most routine blood tests do not require prolonged fasting
  • Pairing cardiac magnetic resonance with electrocardiograms (ECGs) improved artificial intelligence (AI) assessments of cardiovascular diseases
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.